nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.125	0.632	CbGbCtD
Bexarotene—Hypocholesterolaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0769	0.1	CcSEcCtD
Bexarotene—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0727	0.368	CbGbCtD
Bexarotene—Carcinoma—Cyclosporine—focal segmental glomerulosclerosis	0.0212	0.0276	CcSEcCtD
Bexarotene—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.0139	0.0181	CcSEcCtD
Bexarotene—Bacterial infection—Cyclosporine—focal segmental glomerulosclerosis	0.0139	0.0181	CcSEcCtD
Bexarotene—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0154	CcSEcCtD
Bexarotene—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.0151	CcSEcCtD
Bexarotene—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0147	CcSEcCtD
Bexarotene—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0112	0.0145	CcSEcCtD
Bexarotene—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0142	CcSEcCtD
Bexarotene—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0133	CcSEcCtD
Bexarotene—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0131	CcSEcCtD
Bexarotene—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00978	0.0127	CcSEcCtD
Bexarotene—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00889	0.0116	CcSEcCtD
Bexarotene—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00851	0.0111	CcSEcCtD
Bexarotene—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00823	0.0107	CcSEcCtD
Bexarotene—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00823	0.0107	CcSEcCtD
Bexarotene—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00816	0.0106	CcSEcCtD
Bexarotene—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00816	0.0106	CcSEcCtD
Bexarotene—Liver injury—Cyclosporine—focal segmental glomerulosclerosis	0.00761	0.00991	CcSEcCtD
Bexarotene—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00761	0.00991	CcSEcCtD
Bexarotene—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.0075	0.00977	CcSEcCtD
Bexarotene—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00734	0.00956	CcSEcCtD
Bexarotene—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00709	0.00923	CcSEcCtD
Bexarotene—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00704	0.00917	CcSEcCtD
Bexarotene—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00704	0.00917	CcSEcCtD
Bexarotene—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00704	0.00917	CcSEcCtD
Bexarotene—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00695	0.00905	CcSEcCtD
Bexarotene—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00691	0.00899	CcSEcCtD
Bexarotene—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00691	0.00899	CcSEcCtD
Bexarotene—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00686	0.00893	CcSEcCtD
Bexarotene—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00673	0.00876	CcSEcCtD
Bexarotene—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00673	0.00876	CcSEcCtD
Bexarotene—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00652	0.00849	CcSEcCtD
Bexarotene—Hepatocellular injury—Cyclosporine—focal segmental glomerulosclerosis	0.00641	0.00834	CcSEcCtD
Bexarotene—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00629	0.00819	CcSEcCtD
Bexarotene—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00629	0.00819	CcSEcCtD
Bexarotene—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00619	0.00805	CcSEcCtD
Bexarotene—RXRG—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.00614	0.18	CbGpPWpGaD
Bexarotene—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00612	0.00796	CcSEcCtD
Bexarotene—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00608	0.00792	CcSEcCtD
Bexarotene—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00601	0.00783	CcSEcCtD
Bexarotene—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00588	0.00766	CcSEcCtD
Bexarotene—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00579	0.00754	CcSEcCtD
Bexarotene—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00579	0.00754	CcSEcCtD
Bexarotene—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00556	0.00724	CcSEcCtD
Bexarotene—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00556	0.00724	CcSEcCtD
Bexarotene—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00545	0.00709	CcSEcCtD
Bexarotene—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.0053	0.00689	CcSEcCtD
Bexarotene—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00525	0.00683	CcSEcCtD
Bexarotene—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.0052	0.00677	CcSEcCtD
Bexarotene—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0052	0.00677	CcSEcCtD
Bexarotene—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00517	0.00674	CcSEcCtD
Bexarotene—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00515	0.0067	CcSEcCtD
Bexarotene—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00501	0.00653	CcSEcCtD
Bexarotene—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00495	0.00644	CcSEcCtD
Bexarotene—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00489	0.00636	CcSEcCtD
Bexarotene—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00487	0.00633	CcSEcCtD
Bexarotene—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00482	0.00628	CcSEcCtD
Bexarotene—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00478	0.00623	CcSEcCtD
Bexarotene—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00474	0.00618	CcSEcCtD
Bexarotene—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00465	0.00605	CcSEcCtD
Bexarotene—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00461	0.00601	CcSEcCtD
Bexarotene—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00458	0.00596	CcSEcCtD
Bexarotene—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00458	0.00596	CcSEcCtD
Bexarotene—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.00573	CcSEcCtD
Bexarotene—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00436	0.00567	CcSEcCtD
Bexarotene—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00426	0.00555	CcSEcCtD
Bexarotene—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.00534	CcSEcCtD
Bexarotene—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00405	0.00527	CcSEcCtD
Bexarotene—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.00523	CcSEcCtD
Bexarotene—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00394	0.00513	CcSEcCtD
Bexarotene—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00386	0.00503	CcSEcCtD
Bexarotene—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00376	0.00489	CcSEcCtD
Bexarotene—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00371	0.00483	CcSEcCtD
Bexarotene—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.00476	CcSEcCtD
Bexarotene—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00364	0.00473	CcSEcCtD
Bexarotene—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00363	0.00472	CcSEcCtD
Bexarotene—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.0036	0.00469	CcSEcCtD
Bexarotene—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00351	0.00457	CcSEcCtD
Bexarotene—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.00455	CcSEcCtD
Bexarotene—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.00455	CcSEcCtD
Bexarotene—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00348	0.00453	CcSEcCtD
Bexarotene—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00348	0.00453	CcSEcCtD
Bexarotene—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00342	0.00445	CcSEcCtD
Bexarotene—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.0044	CcSEcCtD
Bexarotene—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00336	0.00438	CcSEcCtD
Bexarotene—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.00421	CcSEcCtD
Bexarotene—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.0042	CcSEcCtD
Bexarotene—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.00419	CcSEcCtD
Bexarotene—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.00417	CcSEcCtD
Bexarotene—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.00416	CcSEcCtD
Bexarotene—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.00414	CcSEcCtD
Bexarotene—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00316	0.00412	CcSEcCtD
Bexarotene—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.0041	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.00301	0.0882	CbGpPWpGaD
Bexarotene—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.003	0.0039	CcSEcCtD
Bexarotene—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.0038	CcSEcCtD
Bexarotene—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00289	0.00376	CcSEcCtD
Bexarotene—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00374	CcSEcCtD
Bexarotene—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.0037	CcSEcCtD
Bexarotene—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.00365	CcSEcCtD
Bexarotene—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00359	CcSEcCtD
Bexarotene—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.00358	CcSEcCtD
Bexarotene—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.00357	CcSEcCtD
Bexarotene—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00272	0.00354	CcSEcCtD
Bexarotene—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00269	0.0035	CcSEcCtD
Bexarotene—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.00338	CcSEcCtD
Bexarotene—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00259	0.00337	CcSEcCtD
Bexarotene—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.00335	CcSEcCtD
Bexarotene—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.00329	CcSEcCtD
Bexarotene—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00252	0.00328	CcSEcCtD
Bexarotene—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00326	CcSEcCtD
Bexarotene—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00318	CcSEcCtD
Bexarotene—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.00315	CcSEcCtD
Bexarotene—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.0031	CcSEcCtD
Bexarotene—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.0031	CcSEcCtD
Bexarotene—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.0031	CcSEcCtD
Bexarotene—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00238	0.00309	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00237	0.00308	CcSEcCtD
Bexarotene—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.00307	CcSEcCtD
Bexarotene—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.00304	CcSEcCtD
Bexarotene—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.003	CcSEcCtD
Bexarotene—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00298	CcSEcCtD
Bexarotene—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00227	0.00296	CcSEcCtD
Bexarotene—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00292	CcSEcCtD
Bexarotene—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00291	CcSEcCtD
Bexarotene—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.00289	CcSEcCtD
Bexarotene—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.00288	CcSEcCtD
Bexarotene—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00218	0.00284	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00208	0.00271	CcSEcCtD
Bexarotene—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00269	CcSEcCtD
Bexarotene—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00267	CcSEcCtD
Bexarotene—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00204	0.00265	CcSEcCtD
Bexarotene—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00264	CcSEcCtD
Bexarotene—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.00262	CcSEcCtD
Bexarotene—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00259	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00257	CcSEcCtD
Bexarotene—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00256	CcSEcCtD
Bexarotene—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00254	CcSEcCtD
Bexarotene—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00254	CcSEcCtD
Bexarotene—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.00245	CcSEcCtD
Bexarotene—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00243	CcSEcCtD
Bexarotene—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00235	CcSEcCtD
Bexarotene—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00235	CcSEcCtD
Bexarotene—RXRG—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.00172	0.0504	CbGpPWpGaD
Bexarotene—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00219	CcSEcCtD
Bexarotene—RXRA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—CTGF—focal segmental glomerulosclerosis	0.00167	0.0489	CbGpPWpGaD
Bexarotene—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00213	CcSEcCtD
Bexarotene—RXRB—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.00162	0.0474	CbGpPWpGaD
Bexarotene—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.0021	CcSEcCtD
Bexarotene—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00204	CcSEcCtD
Bexarotene—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.00197	CcSEcCtD
Bexarotene—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00189	CcSEcCtD
Bexarotene—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00188	CcSEcCtD
Bexarotene—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00187	CcSEcCtD
Bexarotene—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00143	0.00186	CcSEcCtD
Bexarotene—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00177	CcSEcCtD
Bexarotene—RXRA—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.00122	0.0358	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.00107	0.0313	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.001	0.0295	CbGpPWpGaD
Bexarotene—RXRA—Vitamin A and Carotenoid Metabolism—LPL—focal segmental glomerulosclerosis	0.000843	0.0247	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000712	0.0209	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—LPL—focal segmental glomerulosclerosis	0.00071	0.0208	CbGpPWpGaD
Bexarotene—RXRA—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.000638	0.0187	CbGpPWpGaD
Bexarotene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—focal segmental glomerulosclerosis	0.000625	0.0183	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—AGT—focal segmental glomerulosclerosis	0.000608	0.0178	CbGpPWpGaD
Bexarotene—RXRA—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.000574	0.0168	CbGpPWpGaD
Bexarotene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.000562	0.0165	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—LPL—focal segmental glomerulosclerosis	0.000529	0.0155	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.000524	0.0154	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.00047	0.0138	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	0.000467	0.0137	CbGpPWpGaD
Bexarotene—RXRA—Circadian Clock—SERPINE1—focal segmental glomerulosclerosis	0.000455	0.0134	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.00045	0.0132	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.000387	0.0113	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000374	0.011	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000352	0.0103	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—LPL—focal segmental glomerulosclerosis	0.000348	0.0102	CbGpPWpGaD
Bexarotene—RXRA—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.00034	0.00998	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000333	0.00976	CbGpPWpGaD
Bexarotene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.000333	0.00976	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000306	0.00897	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—AGT—focal segmental glomerulosclerosis	0.000298	0.00873	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	0.000295	0.00865	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	0.000259	0.00758	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MYH9—focal segmental glomerulosclerosis	0.000247	0.00723	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	0.000238	0.00697	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.000229	0.00673	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	0.000229	0.00671	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—focal segmental glomerulosclerosis	0.00022	0.00644	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	0.00019	0.00558	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	0.000183	0.00537	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.00018	0.00528	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000175	0.00513	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.000171	0.005	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—CTGF—focal segmental glomerulosclerosis	0.000169	0.00496	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000161	0.00473	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	0.00016	0.0047	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000154	0.00452	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	0.000144	0.00424	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	0.000132	0.00386	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.00012	0.00351	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000107	0.00313	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	0.000106	0.00311	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	9.14e-05	0.00268	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—CTGF—focal segmental glomerulosclerosis	8.83e-05	0.00259	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	8.36e-05	0.00245	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	8.21e-05	0.00241	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP2—focal segmental glomerulosclerosis	8.02e-05	0.00235	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LIPC—focal segmental glomerulosclerosis	7.79e-05	0.00229	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	7.72e-05	0.00226	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	7.01e-05	0.00206	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CTGF—focal segmental glomerulosclerosis	6.86e-05	0.00201	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.67e-05	0.00195	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.53e-05	0.00192	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.32e-05	0.00185	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—MMP9—focal segmental glomerulosclerosis	6.03e-05	0.00177	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.75e-05	0.00169	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	4.97e-05	0.00146	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—LPL—focal segmental glomerulosclerosis	4.76e-05	0.00139	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AGT—focal segmental glomerulosclerosis	4.07e-05	0.00119	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	4.02e-05	0.00118	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.99e-05	0.00117	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.41e-05	0.001	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALB—focal segmental glomerulosclerosis	3.12e-05	0.000916	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	2.91e-05	0.000853	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.62e-05	0.000767	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	2.56e-05	0.000751	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.36e-05	0.000692	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.92e-05	0.000563	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	1.78e-05	0.000521	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.69e-05	0.000495	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.56e-05	0.000456	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	1.52e-05	0.000445	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.17e-05	0.000343	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	1.17e-05	0.000342	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	1e-05	0.000294	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	7.69e-06	0.000225	CbGpPWpGaD
